Investing.com - Goldman Sachs (NYSE: GS) has resumed coverage on CG Oncology (NASDAQ: CGON) with a Buy rating and a price target of $40.00 on Thursday. The stock, currently trading at $27.04, appears ...

Investing.com - Morgan Stanley (NYSE: MS) has resumed coverage of Verizon Communications (NYSE: VZ) with an Equalweight rating and a $47.00 price target, according to a research note released Thursday ...

Investing.com - Morgan Stanley has resumed coverage of Verizon Communications (NYSE: VZ) with an Equalweight rating and a $47.00 price target, according to a research note released Thursday. The ...

Analyst Ratings Published 07/10/2025, 03:12 AM 0 Goldman Sachs resumes Amylyx stock coverage with Buy rating on avexitide potential AMLX 0.00% ...

Investing.com - Jefferies has resumed coverage on Flutter Entertainment (NYSE: FLUT) with a Buy rating and a price target of $380.00. The gambling giant, currently valued at over $50 billion, has ...

Investing.com - Citi has resumed coverage on Alcoa (NYSE: AA) with a Buy rating and a $42.00 price target, according to a research note released Monday. Currently trading at $29.81, InvestingPro ...

Intel Corp. research and ratings by Barron's. View INTC revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.

The company has withstood a tragic month, and Redburn upgraded shares to Buy from Neutral.

Explore the Global Cancer Vaccine Market's growth from $12.16 billion in 2024 to an expected $20.88 billion by 2031. Driven by innovations in immuno-oncology, the market is dominated by ...